Edited by
Albert Li, In Vitro Technologies, Inc., and University of Maryland Technology Center, Baltimore, Maryland, U.S.A.
Series Editor:
J. August, John Hopkins University; Department of Pharmacology, Baltimore, Maryland, U.S.A.
Ferid Murad, University of Texas Medical School, Houston, U.S.A.
M. Anders, University of Rochester; Department of Pharmacology, New York, U.S.A.
Joseph Coyle, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, U.S.A.
Description
Drug–Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug–drug
interactions from the point-of-view of academia, industry, and government regulatory agencies. This book is intended for professionals
in the pharmaceutical industry, health care, and governmental regulatory agencies. Topics of interest include the mechanistic understanding
of drug–drug interactions, the prediction of drug–drug interaction potential of new drugs, and the avoidance of clinically
significant drug–drug interaction in patients.
Included in series
Advances in Pharmacology
Audience:
Professionals in the pharmaceutical industry, health care industry, and governmental regulatory agencies. Students and researchers in
the areas of pharmacology, toxicology, pharmacokinetics, and medicine.
